Noradrenaline Neuron Degeneration Contributes to Motor Impairments and Development of L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease

Experimental Neurology - United States
doi 10.1016/j.expneurol.2014.04.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-Dopa-Induced Dyskinesia in Rat Model of Parkinson's Disease

PLoS ONE
Multidisciplinary
2011English

Differential Involvement of D1 and D2 Dopamine Receptors in L-Dopa-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2009English

L-Dopa Methyl Ester Antagonizes Competitively L-Dopa-Induced Facilitation of Noradrenaline Release From Rat Hypothalamic Slices.

The Japanese Journal of Pharmacology
1990English

Opioid System in L-Dopa-Induced Dyskinesia

Translational Neurodegeneration
Molecular NeuroscienceNeurologyCellularCognitive Neuroscience
2017English

Maladaptive Synaptic Plasticity in L-Dopa-Induced Dyskinesia

Frontiers in Neural Circuits
Molecular NeuroscienceSensory SystemsNeuroscienceCellularCognitive Neuroscience
2016English

A Computational Model of Motor Neuron Degeneration

Neuron
Neuroscience
2014English

Nitric Oxide a New Player in L-Dopa-Induced Dyskinesia

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Sensitivity of EQ-5D to Clinical Change in Patients With Parkinson’s Disease L-Dopa Induced Dyskinesia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

L-Dopa for Parkinson's Disease - A Bittersweet Pill

European Journal of Neuroscience
Neuroscience
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy